Is Spire Healthcare Group (LSE:SPI) Still Undervalued On Fresh Institutional Interest?

Simply Wall St · 2d ago

Dimensional Fund Advisors has disclosed a 2.19% interest in Spire Healthcare Group (LSE:SPI) under Rule 8.3 of the Takeover Code, putting the hospital operator on institutional radars.

Spire Healthcare Group’s share price has climbed 46.45% on a year to date basis and recorded a 7.14% share price return over the past 90 days, while the 1 year total shareholder return of 9.29% points to more muted gains once dividends and any capital actions are included. Recent disclosures from Dimensional Fund Advisors signal fresh institutional interest, which may reflect shifting views on Spire’s growth prospects and risk profile at the current £2.475 price level.

Compare how Spire Healthcare Group’s institutional interest and valuation stack up against a curated pool of 17 high quality undervalued stocks that also combine cash generation with balance sheet strength.

After a 46.45% year to date jump, Spire Healthcare Group now trades only modestly below the average analyst target, while some intrinsic value estimates sit far lower. Where does fair value really land in that spread?

Most Popular Narrative: 6% Undervalued

On the analyst consensus Narrative on Simply Wall St, Spire Healthcare Group screens as modestly undervalued, with a fair value of £2.64 against the latest £2.48 close, and that view leans heavily on quantified private demand and cost savings.

Ongoing transformation, centralisation and digital and AI programmes, including more than £30m of targeted cost savings for 2026 after £30m delivered in 2025, are aimed at holding margins and supporting earnings despite structural wage and National Insurance cost inflation.

See why 16 investors see Spire Healthcare Group as 6% undervalued.

Result: Fair Value of £2.64 (UNDERVALUED)

Still, the Spire Healthcare Group story can wobble if NHS volumes weaken faster than private demand fills the gap, or if cost savings repeatedly require fresh one off charges.

Find out about the key risks to this Spire Healthcare Group narrative.

Next Steps

Curious whether the market optimism around Spire Healthcare Group feels justified or stretched at this point in the story? Move quickly, review the underlying data for yourself, and pressure test the upside by checking the 3 key rewards.

Looking for more investment ideas beyond Spire Healthcare Group?

If Spire Healthcare Group has caught your attention, do not stop there. Broaden your watchlist now with focused stock ideas that match different risk and income goals.

  • Target income-first opportunities by reviewing companies that screen as potential 4 dividend fortresses and may appeal if you prioritise yield alongside fundamentals.
  • Hunt for mispriced potential by scanning a curated pool of 5 high quality undiscovered gems that combine quality metrics with relatively low market attention.
  • Dial down volatility risk by focusing on a 5 resilient stocks with low risk scores that can help you spot businesses flagged for more resilient financial profiles.